Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20776 - 20800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cyclophosphamide	Approved Investigational	PRTN3	5657	downregulated	Cyclophosphamide results in decreased expression of PRTN3 mRNA	19p13.3	A21865
Cyclophosphamide	Approved Investigational	RAMP1	10267	upregulated	Cyclophosphamide results in increased expression of RAMP1 mRNA	2q37.3	A21865
Cyclophosphamide	Approved Investigational	RBPMS	11030	upregulated	Cyclophosphamide results in increased expression of RBPMS mRNA	8p12	A21865
Cyclophosphamide	Approved Investigational	RIPPLY3	53820	upregulated	Cyclophosphamide results in increased expression of RIPPLY3 mRNA	21q22.13	A21863
Cyclophosphamide	Approved Investigational	RNASE2	6036	downregulated	Cyclophosphamide results in decreased expression of RNASE2 mRNA	14q11.2	A21865
Cyclophosphamide	Approved Investigational	RRAGA	10670	downregulated	Cyclophosphamide results in decreased expression of RRAGA mRNA	9p22.1	A21865
Cyclophosphamide	Approved Investigational	RRAS2	22800	upregulated	Cyclophosphamide results in increased expression of RRAS2 mRNA	11p15.2	A21865
Cyclophosphamide	Approved Investigational	RRM2B	50484	upregulated	Cyclophosphamide metabolite results in increased expression of RRM2B mRNA	8q22.3	A21622
Cyclophosphamide	Approved Investigational	RUNX3	864	downregulated	Cyclophosphamide results in decreased expression of RUNX3 mRNA	1p36.11	A20660
Cyclophosphamide	Approved Investigational	S100P	6286	downregulated	Cyclophosphamide results in decreased expression of S100P mRNA	4p16.1	A21865
Cyclophosphamide	Approved Investigational	SESN2	83667	downregulated	Cyclophosphamide metabolite results in decreased expression of SESN2 mRNA	1p35.3	A20727
Cyclophosphamide	Approved Investigational	SFN	2810	upregulated	Cyclophosphamide results in increased expression of SFN mRNA	1p36.11	A21863
Cyclophosphamide	Approved Investigational	SGK1	6446	downregulated	Cyclophosphamide metabolite results in decreased expression of SGK1 mRNA	6q23.2	A20727
Cyclophosphamide	Approved Investigational	SLC2A6	11182	upregulated	Cyclophosphamide results in increased expression of SLC2A6 mRNA	9q34.2	A21863
Cyclophosphamide	Approved Investigational	SLC3A2	6520	downregulated	Cyclophosphamide metabolite results in decreased expression of SLC3A2 mRNA	11q12.3	A20727
Cyclophosphamide	Approved Investigational	SLC43A1	8501	downregulated	Cyclophosphamide metabolite results in decreased expression of SLC43A1 mRNA	11q12.1	A20727
Cyclophosphamide	Approved Investigational	SLC7A11	23657	downregulated	Cyclophosphamide metabolite results in decreased expression of SLC7A11 mRNA	4q28.3	A20727
Cyclophosphamide	Approved Investigational	SLIT1	6585	downregulated	Cyclophosphamide results in decreased expression of SLIT1 mRNA	10q24.1	A20660
Cyclophosphamide	Approved Investigational	SPARC	6678	upregulated	Cyclophosphamide results in increased expression of SPARC mRNA	5q33.1	A21865
Cyclophosphamide	Approved Investigational	STMN3	50861	upregulated	Cyclophosphamide results in increased expression of STMN3 mRNA	20q13.33	A21863
Cyclophosphamide	Approved Investigational	STOM	2040	upregulated	Cyclophosphamide results in increased expression of STOM mRNA	9q33.2	A21863
Cyclophosphamide	Approved Investigational	TAP1	6890	upregulated	Cyclophosphamide results in increased expression of TAP1 mRNA	6p21.32	A21863
Cyclophosphamide	Approved Investigational	TEX30	93081	downregulated	Cyclophosphamide results in decreased expression of TEX30 mRNA	13q33.1	A21865
Cyclophosphamide	Approved Investigational	TM4SF1	4071	upregulated	Cyclophosphamide results in increased expression of TM4SF1 mRNA	3q25.1	A21865
Cyclophosphamide	Approved Investigational	TM6SF1	53346	downregulated	Cyclophosphamide metabolite results in decreased expression of TM6SF1 mRNA	15q25.2	A20727

Displaying entries 20776 - 20800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability